Benefit to who? Did a doc get a free pad, some literature and these days, a lunch seminar? Yes. Do they use the pad? Yes. Are the pads (commonly for a product that has little to no insurance coverage and/or is ridiculous to even stock) conveniently marked 'do not substitute' even though the doc doesn't care? Yes. Does such usually just lead to headache and wasted time for all parties involved except the rep? Yep, along with the rx getting changed away from his/her product anyway. But, do such things (rep visits, pads, etc) definitely impact prescribing practices? Yes. Coupons definitely do due to usually being zero or low copay to the patient. Common problem there is just like samples---take something one or a few times and find that it works and THEN discover that it's nonformulary and gonna cost $247. (Remember, you don't get a Fluke congressional hearing to rant). Another issue is what I mentioned earlier, docs have no conception of actual cost/pricing on medications---especially the morons who rattle off 'take this to Walmart, it's $4'. Often that's not the case anyway but even when it is the vast majority of the time the overall bill will inevitably be considerably higher for the patient due to following that instruction/suggestion. Patients are unaware as well. They often have no idea that the $25 copay they paid goes along with the $300 the insurance paid. Sure it's partly due to what I do, but I truly believe ignorance regarding various pharm issues plays a major role in the wreck we're in and I believe it extends to other providers as well. I think jaeger, Cabela, and Paddler would back me up on that with regards to their fields specifically and also in others.